Cme Group INC Form 4 insider transactions

William R Shepard, a Director of Cme Group Inc., purchased 293 shares of common stock on September 25, 2026 for $268.76 per share.

Julie Winkler, Sr MD Chief Commercial Officer of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Ken Vroman, Chief Transformation Officer of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Jack J Tobin, MD Chief Accounting Officer of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Suzanne Sprague, COO & Global Head of Clearing of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Derek Sammann, Sr MD Gl Hd Commodities Mkts of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Timothy Francis Mccourt, Sr MD Global Head Equity & FX of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

John Clifford Marchese, Sr MD, General Counsel of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Lynne Fitzpatrick, President and CFO of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Terrence A Duffy, Chairman and CEO and a Director of Cme Group Inc., received 21,812 shares of common stock on September 15, 2026.

Michael G. Dennis, Global Head of Fixed Income of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Sunil Cutinho, Chief Information Officer of Cme Group Inc., reported multiple transactions in common stock on September 15, 2026.

Elizabeth A Cook, a Director of Cme Group Inc., sold 500 shares of common stock on September 14, 2026 for $280.11 per share.

Terrence A Duffy, Chairman and CEO and a Director of Cme Group Inc., sold 15,000 shares of common stock on September 10, 2026.

Robert J. Tierney Jr., a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Martin J. Gepsman, a Director at CME Group Inc., received a grant of 645 fully vested shares of Class A Common Stock as part of the company's annual equity compensation program.

William R. Shepard, a Director at CME Group Inc., reported transactions involving the acquisition of common stock, including grants and dividend reinvestments.

Rahael Seifu, a Director at CME Group Inc., was granted fully vested Class A Common Stock as part of the company's annual equity compensation program.

Dennis Suskind, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Howard J. Siegel, a Director at CME Group Inc., reported transactions involving the acquisition of Class A Common Stock.

Patrick J. Mulchrone, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Patrick W. Maloney, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Deborah J. Lucas, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Phyllis M. Lockett, a Director at CME Group Inc., was granted fully vested Class A Common Stock as part of the company's annual equity compensation program.

CME Group Director Daniel G. Kaye was granted fully vested Class A Common Stock as part of the company's annual equity compensation program.

William W. Hobert, a Director at CME Group Inc., has reported several transactions involving Class A Common Stock, including distributions, grants, and elected share issuances.

Harold Eugene Ford Jr. reports transactions involving CME Group Inc. Class A Common Stock, including grants and shares issued in lieu of director fees.

Bryan T. Durkin, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Elizabeth A. Cook, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the annual compensation program.

CME Group Director Charles P. Carey acquired shares through the company's annual equity compensation program and in lieu of cash retainer.